-
Why Gene Therapy Is No Longer A Pipe Dream
Jan 18, 2018, 10:27 AM by Michael CroftPacific Standard | After decades of disappointment, cures to once-incurable diseases seem within reach.Full story -
Almac Group announces further expansion at its European Campus in Dundalk
Jan 18, 2018, 08:47 AM by Michael Croft- Jan 18, 2018 - Craigavon, N.I., 18 January 2018 - Almac Group, the global contract pharmaceutical development and manufacturing organisation, today confirmed the successful completion of Health Products Regulatory Authority (HPRA) inspections of Almac Clinical Services Ireland and Almac Pharma Services Ireland at its European campus in Dundalk, IrelandFull story -
Brazilian Health Surveillance Agency, ANVISA, Adopts Certara’s Phoenix Software for Drug Regulatory Reviews
Jan 17, 2018, 13:52 PM by Michael CroftPRINCETON, NJ - Jan 17, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that the Brazilian National Health Surveillance Agency – ANVISA (Agência Nacional de Vigilância Sanitária) – is now also employing Certaras Phoenix® WinNonlin® software for reviewing drug regulatory submissionsFull story -
WilsonHCG Unveils Fourth Annual Fortune 500 Top 100 Employment Brands Report
Jan 17, 2018, 13:05 PM by Michael CroftTAMPA, FL, UNITED STATES - Jan 17, 2018 - WilsonHCG, global leader and premium provider of innovative talent solutions, has revealed its 2018 Fortune 500 Top 100 Employment Brands report – the companys fourth annual objective research, evaluation and ranking of how well Fortune 500 organizations brand themselves as an employer of choiceFull story -
Celgene In Talks To Buy Juno Therapeutics
Jan 17, 2018, 10:29 AM by Michael CroftNew York Business Journal | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction.Full story -
Has Bio-IT Soured On Cloud?
Jan 17, 2018, 08:15 AM by Michael CroftFull storyBio-IT World | Bio-IT has swung the gamut of opinions on cloud solutions. First wary, then warming, now, perhaps, pulling back. The inconsistency comes as use cases evolve and costs are closely watched. But there’s no denying that the cloud lets researchers do things they’ve never done before. The trick is finding the right balance.
-
44% of Life Science Professionals Already Using or Experimenting with AI and Deep Learning, Finds Su(1)
Jan 16, 2018, 12:00 PM by Michael CroftBOSTON, MA - Jan 9, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling on the pharmaceutical and technology industries to support greater collaboration around Artificial Intelligence (AI) in pharmaceutical R&DFull story -
Howard Jacob Leaving HudsonAlpha For AbbVie
Jan 16, 2018, 09:10 AM by Michael CroftFull storyBio-IT World | Less than three years after leaving the Medical College of Wisconsin for the HudsonAlpha Institute in Huntsville, Alabama, Howard Jacob is starting today as the Vice President of the Genomic Research Center at AbbVie.
-
Aalto Bio Reagents Announces Availability of Mouse Monoclonal Antibody to Helicobacter Pylori Flagellin for Diagnostic Testing
Jan 16, 2018, 07:37 AM by Michael CroftDUBLIN, IRELAND - Jan 16, 2018 - Dublin, Ireland – January 16th, 2018 –Aalto Bio Reagents is pleased to announce availability of its new mouse monoclonal antibody to Helicobacter pylori flagellin for diagnostic test manufacturers, vaccine developers and researchers globallyFull story -
Bioinformatics firm Mind the Byte acquires Intelligent Pharma
Jan 16, 2018, 06:34 AM by Michael CroftBARCELONA, SPAIN - Jan 16, 2018 - Bioinformatics firm Mind the Byte, a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industryFull story -
DNA Sequencing Holds Some Promise For Treating Tumors
Jan 15, 2018, 16:08 PM by Michael CroftNPR | Sequencing the DNA of cancer tumors to help pinpoint treatment is an emerging element of precision medicine. While patients and doctors alike want these tests, they often don't benefit patients.Full story -
23andMe CEO Goes Beyond “Wall Of A White Coat”
Jan 15, 2018, 12:55 PM by Michael CroftFull storyBio-IT World | Speaking at the 36th annual JP Morgan Healthcare Conference, 23andMe’s CEO and co-founder Anne Wojcicki reflected on the scope of the 23andMe’s dataset, especially as it pertains to healthcare and drug discovery.
-
Meditraq launches to simplify serialisation data challenge
Jan 15, 2018, 11:44 AM by Michael CroftETTEN-LEUR, NETHERLANDS - Jan 15, 2018 - A new serialisation implementation partner has formed to assist the increasing number of companies needing to meet the data requirements of looming global regulation changesFull story -
JP Morgan 2018 News Roundup
Jan 12, 2018, 13:35 PM by Michael CroftFull storyBio-IT World | The 36th annual JP Morgan Healthcare Conference was held this week in San Francisco, bringing together more than 400 companies to showcase their growth and innovation. Here are some of the highlights and announcements we’ve collected from the conference.
-
Nonprofit Price For New Childhood Blindness Therapy 4X Too High
Jan 12, 2018, 12:22 PM by Michael CroftSTAT | Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.Full story -
BioIVT Launches Scientific Advisory Board, Expands Drug Development Expertise
Jan 11, 2018, 10:23 AM by Michael CroftWESTBURY, NY - Jan 11, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced the launch of its BioIVT Scientific Advisory Board (SAB)Full story -
MDI Biological Laboratory Discovery Could Lead to New Therapies for Diabetics
Jan 10, 2018, 16:42 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Jan 10, 2018 - New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetesFull story -
TARGET PharmaSolutions to advance NASH Research through New Collaboration
Jan 10, 2018, 10:46 AM by Michael CroftCHAPEL HILL, NC - Jan 10, 2018 - TARGET PharmaSolutions, Inc., a real-world data solutions company, is pleased to announce that Novartis has entered into a long-term strategic alliance for TARGET-NASHFull story -
Genedata Screener Raises the Bar on Automation in 2018
Jan 9, 2018, 10:09 AM by Michael CroftBASEL, SWITZERLAND - Jan 9, 2018 - Genedata, a leading provider of advanced software solutions for R&D, today announced that Genedata Screener® has been enhanced towards full automation of the planning, execution, and data analysis of screening experimentsFull story -
BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology
Jan 9, 2018, 02:18 AM by Michael Croft